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A B S T R A C TObjectives: This article reports on the ﬁndings from applying a
recently described approach to modeling health state valuation data
and the impact of the respondent characteristics on health state
valuations. The approach applies a nonparametric model to estimate
a Bayesian six-dimensional health state short form (derived from
short-form 36 health survey) health state valuation algorithm. Meth-
ods: A sample of 197 states deﬁned by the six-dimensional health
state short form (derived from short-form 36 health survey)has been
valued by a representative sample of the Hong Kong general popula-
tion by using standard gamble. The article reports the application of
the nonparametric model and compares it to the original model
estimated by using a conventional parametric random effects model.
The two models are compared theoretically and in terms of empirical
performance. Results: Advantages of the nonparametric model aresee front matter Copyright & 2013, International S
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ondence to: Samer A. Kharroubi, Department of Mathat it can be used to predict scores in populations with different
distributions of characteristics than observed in the survey sample and
that it allows for the impact of respondent characteristics to vary by
health state (while ensuring that full health passes through unity). The
results suggest an important age effect with sex, having some effect,
but the remaining covariates having no discernible effect. Conclusions:
The nonparametric Bayesian model is argued to be more theoretically
appropriate than previously used parametric models. Furthermore, it is
more ﬂexible to take into account the impact of covariates.
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There has been an increasing use of preference-based measures
of health-related quality of life to calculate quality-adjusted life-
years (QALYs) for use in cost-effectiveness analyses. These
preference-based measures are standardized multidimensional
health state classiﬁcations with preference or utility weights
elicited from a sample of the general population [1]. There are
currently a number of such preference-based measures, includ-
ing the generic EuroQol ﬁve-dimensional (EQ-5D) questionnaire
[2], health utilities index 2 (HUI2)and 3 [3,4], 15D [5,6], Assessment
of Quality of Life [7], Quality of Well-being scale (QWB) [8], and the
six-dimensional health state short form (derived from short-form
36 health survey) (SF-6D) [9]. Condition-speciﬁc preference-based
measures have also been developed [10,11]. These measures
provide empirically derived health state value that can be used
to derive QALYs for use in a cost-effectiveness analysis [12]. A key
problem for these measures has been the large number of unique
health states that they deﬁne, such that it is not feasible to obtain
direct valuations for each health state. Thus, models are con-
structed to predict the values for all states in a descriptive system
based on direct valuations of a sample of states.
Health state values present a signiﬁcant challenge for conven-
tional statistical modeling procedures due to their nature,
namely, skewed, truncated, noncontinuous, and hierarchical [9].Attempts to statistically model these data have met with some
success in the SF-6D [9], EQ-5D questionnaire [13], and HUI2 [14].
For these instruments, however, there are concerns with the size
of the prediction errors, and for the SF-6D, there is a problem of
nonmonotonicity (where some better states are assigned a lower
value than worse states) and an apparent systematic pattern in
the prediction errors (involving overprediction of the value of
poor health states and underprediction of the value of good
health states). Furthermore, these methods are limited in the way
they are able to model the impact of covariates on health state
values. The main limitation is that covariates are modeled only in
terms of their impact on the intercept. It is worth noting that this
is not a weakness of parametric methods per se because it is
perfectly reasonable to interact covariates with the levels of the
SF-6D, rather the parametric methods that have been used in
articles in this speciﬁc area. These results in the intercept
deviating from unity, which contravenes the requirement that
full health equals 1 on the conventional full health-death scale
used to estimate QALYs. It also means that the impact of a
covariate is assumed to be the same regardless of the state; so,
for example, the impact is the same regardless of the severity of
the state. This is an unrealistic assumption.
Kharroubi et al. [15] reported an alternative, nonparametric
Bayesian method for modeling health state preference data.
Their method describes the intrinsic characteristics of individualociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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theoretically appropriate than previously used parametric mod-
els. Furthermore, this method is more ﬂexible to take into
account the impact of covariates, which 1) enables the estimation
of the impact of covariates on the state as a whole and not just
the intercept term, and 2) allows for the fact that each individual
values several states, by incorporating individual random effects
that can be linked to covariates and retain the feature that perfect
health should have a value of 1. Kharroubi et al. [16] reported the
ﬁndings from applying this method to modeling SF-6D UK health
state valuation data, and Kharroubi et al. [17] extended the
method to address covariates in the SF-6D UK data. Kharroubi
and McCabe [18] have also applied it to the HUI2 UK valuation
data. In this article, we report the application of this method to
the SF-6D HK valuation data reported by McGhee et al. [19] and
compare the results with the conventional random-effect regres-
sion model. It is worth mentioning that the method presented in
this article is a replication of the method used to model the UK
data nonparametrically (the Kharroubi et al. [15–17] articles
describe this at length). Thus, while it does not provide new
methodological advances, it further emphasizes the point made
in the Kharroubi et al. articles [15–17] that the nonparametric
approach performs well.
The second section of this article brieﬂy describes the SF-6D
HK valuation study and the data used in this article. A detailed
description has been reported elsewhere [19]. The third section
sets out the parametric and nonparametric approaches for health
state valuations. The next section presents the results from each
approach and compares the models in terms of their ability to
predict actual values and to estimate the impact of covariates.
Finally, we conclude with a discussion of the results and their
implication for future use of the SF-6D and modeling work in
this ﬁeld.The SF-6D HK Data Set
The SF-6D, derived from the SF-36, is a generic measure of health
[20]. It is composed of six multilevel dimensions of health:
physical functioning, role limitation, social functioning, bodily
pain, mental health, and vitality. It was constructed from a
sample of 11 items selected from the SF-36 to minimize the loss
of descriptive information [9]. The six dimensions have between
four and six levels. An SF-6D health state is deﬁned by selecting
one statement from each dimension, starting with physical
functioning and ending with vitality. Level 1 in each dimension
represents no loss of health or functioning in that dimension, so
that state 111111 denotes perfect health. The worst possible state
is 645655, known as “the pits.” A total of 18,000 health states can
be deﬁned in this way.
The Chinese Hong Kong (HK) version of the SF-6D was derived
from the English UK version by forward-backward translations
(Table 1). The SF-6D HK was ﬁeld tested in a pilot study and
showed that the valuation method was feasible and the resulting
data were reliable and ﬁtted quite well in an econometric model
[21]. A selection of 197 (196 states plus perfect health) states
deﬁned by the SF-6D have been valued by a representative
sample of the HK general population by using the standard
gamble (SG) technique [19]. The 196 health states were selected
in two ways. One part of the sample was identiﬁed by using an
orthogonal design (by applying the Orthoplan procedure of SPSS)
that generates 49 health states to estimate an additive model. A
further 147 states were selected by using a stratiﬁed random
sampling method to ensure a balance of mild, moderate, and
severe states. All states were checked to ensure that they
described credible combinations of dimension levels [19].The face-to-face interview procedure was modeled on that
used in the UK study [9], which was based on methodology
developed at McMaster University, Canada. Each participant was
asked to rank a set of 10 health state cards and then rate them by
using a visual analogue scale of 0 to 100 points, where the end
points were the best and the worst imaginable health states. This
ranking and rating exercise was followed by the SG procedure
[19]. While evaluating each of the seven health states, the
participants were asked to choose between an intervention
(choice A) involving uncertain health outcomes and a certain
health state deﬁned by the SF-6D HK states (choice B). There were
two possible health outcomes in choice A: the best health state
(H) if the treatment was successful and the worst health state (K)
if the treatment failed. The seven health states were placed in
choice B one by one as the certain health state under valuation.
Once the seven states had been valued, an eighth choice was
presented. The reference state in choice A was represented by the
state judged by this individual as the poorest, either K or L. The
other one of states K or L then became choice B. This enabled
valuation of K against L. (See McGhee et al. [19] for more details.)
Choice A, the intervention, involved the best health outcome
with probability P and the worst health outcome with probability
1 – P. The probability of the outcomes was varied until the
respondent was indifferent between choosing A or B. At that
point, the preference-based utility value of the health state in
choice B was reached and was reﬂected by the probabilities of the
outcomes. For example, if the respondent was indifferent when
the probability of the best outcome was 80% and the worst was
20%, then the utility value was taken as 0.80. Probabilities in
terms of percentages for the certain/uncertain outcomes were
varied in the following order: 0/100, 90/10, 10/90, 80/20, 20/80, 70/
30, 30/70, 60/40, 40/60, and 50/50. This is called the “ping-pong
method” because it alternates between a “good” state and a
“poor” state. Respondents were asked to give reasons if they had
chosen choice B for 100/0 and choice A for 0/100 because these
were considered as illogical answers. See McGhee et al. [19] for
more details.
The respondent was asked for further information on marital
status, number of children, employment, place of birth, number
of family members, type of housing, household income, medical
beneﬁts, and health-related questions to control for these in the
analysis [19]. The value for each health state was then trans-
formed to a scale, with 1 as perfect health and 0 equivalent to
death. This adjusted SG value forms the dependent variable (y) in
the models discussed below.
Of the 641 participants in the face-to-face interviews, 29 (4.5%)
were excluded from the analysis because they failed to appro-
priately value the pits state and it was therefore not possible to
generate an adjusted SG value for them. Most of these partic-
ipants (28 out of 29) gave an illogical valuation for the pits state. A
further 30 participants who gave the same valuation for each of
the seven intermediate SF-6D HK health states were also
excluded, leaving data of 582 participants (641 – 29 – 30) for
analysis. Each of the 582 respondents made 8 SG valuations,
giving 4656 valuations. Of these, 60 (1.3%) were illogical, and so
4596 (4656 – 60) SG valuations across 197 health states (196 states
plus the pits state) were ﬁnally included in the analysis. The 59
excluded cases tended to be older, male, and smokers and had
lower educational qualiﬁcations. See McGhee et al. [19] for more
details.
Each health state was valued at least 16 times and, on
average, 20 times. The mean heath state values ranged from
0.0670 for the pits state 645655 to 0.8584 for the state 211111, and
had large SDs. There were 158/197 (80%) health states with a
median value greater than the mean value, indicating that the
data were skewed left (negative skew). Negative values did occur
but were relatively rare (383 of 4596, 8%), and 556 of 4596 (12%)
Table 1 – The Hong Kong version of the SF-6D (McGhee et al. [19]).
Level Physical Functioning Level Pain
1 Your health does not limit you in vigorous activities 1 You have no pain
2 Your health limits you a little in vigorous activities 2 You have pain but it does not interfere with your
normal work (both outside the home and
housework)
3 Your health limits you a little in moderate activities 3 You have pain that interferes with your normal
work (both outside the home and housework) a
little bit
4 Your health limits you a lot in moderate activities 4 You have pain that interferes with your normal
work (both outside the home and housework)
moderately
5 Your health limits you a little in bathing and dressing 5 You have pain that interferes with your normal
work (both outside the home and housework)
quite a bit
6 Your health limits you a lot in bathing and dressing 6 You have pain that interferes with your normal
work (both outside the home and housework)
extremely
Role limitations Mental health
1 You have no problems with your work or other regular daily
activities as a result of your physical health or any emotional
problems
1 You feel tense or downhearted and low none of
the time
2 You are limited in the kind of work or other activities as a result
of your physical health
2 You feel tense or downhearted and low a little of
the time
3 You accomplish less than you would like as a result of emotional
problems
3 You feel tense or downhearted and low some of
the time
4 You are limited in the kind of work or other activities as a result
of your physical health and accomplish less than you would
like as a result of emotional problems
4 You feel tense or downhearted and low most of
the time
5 You feel tense or downhearted and low all of the
time
Social functioning Vitality
1 Your health limits your social activities none of the time 1 You have a lot of energy all of the time
2 Your health limits your social activities a little of the time 2 You have a lot of energy most of the time
3 Your health limits your social activities some of the time 3 You have a lot of energy some of the time
4 Your health limits your social activities most of the time 4 You have a lot of energy a little of the time
5 Your health limits your social activities all of the time 5 You have a lot of energy none of the time
Note. The SF-36 items used to construct the SF-6D are as follows: physical functioning items 1, 2, and 10; role limitation due to physical
problems item 3; role limitation due to emotional problems item 2; social functioning item 2; both bodily pain items; mental health items 1
(alternate version) and 4; and vitality item 2.
SF-6D, six-dimensional health state short form (derived from SF-36); SF-36, short-form 36 health survey.
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respondents (354 of 582, 61%) valued the pits state better than
death. The details of the valuations for each of the 197 SF-6D HK
health states are given in McGhee et al. [19].Modeling
The generic SF-6D descriptive system describes 18,000 possible
health states, and the empirical survey could obtain valuations
for only a small subset. The aim of modeling is to estimate health
state utility values for all states. The utility associated with a
health state is assumed to be a function of that state; hence, by
estimating a relationship between the descriptive system and the
observed values, we can infer values for all states. Valuation
surveys generate data with a complex structure creating a
number of problems for estimation, and a variety of techniques
have been used to deal with these problems, one of which is
between respondent variations. In the main, these have used
parametric relationships with particular assumptions about func-
tional form, but here we contrast this conventional parametricapproach reported by McGhee et al. [19] with a more ﬂexible
Bayesian nonparametric model.
A general model for health state valuations can be described
by (see Kharroubi et al. [15] and McGhee et al. [19])
yij¼ f ðxij,αjÞþεij ð1Þ
where for i ¼ 1, 2,…, nj and j ¼ 1, 2,…, m, xij is the ith health state
valued by respondent j and the dependent variable yij is the
adjusted SG score given by respondent j for that health state. The
general model has two sets of independent, zero-mean, random
effect terms: εij is a random error term associated with each
observation, and αj is a term to allow for individual character-
istics of respondent j.
The interpretation of f ðxij,αjÞ is as the true indifference SG
value that respondent j has for health state xij. The objective is to
obtain a health state utility measure for the population as a
whole, and this is generally taken to be the mean of the
respondent-level health state utilities across the population. To
account for different populations, it is possible to model αj in
terms of respondent-level covariates such as age, gender, or
socioeconomic factors.
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McGhee et al. [19] specify the following model for respondent j’s
health state utility:
f ðxij,αjÞ¼μþIðxijÞþαj ð2Þ
where μ and h denote unknown parameters and IðxijÞ is a vector of
dummy explanatory variables. In the simplest, no-interactions,
case of this model, IðxijÞ is a vector of terms IδλðxijÞ for each level
λ > 1 of dimension δ of the SF-6D. For example, I32ðxijÞ denotes
dimension δ ¼ 3 (social functioning), level λ ¼ 2 (health limits
social activities a little of the time). For any given health state xij,
IδλðxijÞ is deﬁned as follows:
IδλðxijÞ ¼ 1 if, for state xij, dimension δ is at level λ
IδλðxijÞ ¼ 0 if, for state xij, dimension δ is not at level λ
In all, there are 25 of these terms, with level λ ¼ 1 acting as a
baseline for each dimension. Hence, the intercept parameter μ
represents the health state utility value for state (111111), and
summing the coefﬁcients θδλ of the “on” dummies and adding this
to the intercept derives the value of any other state.
More generally, IðxijÞ can include additional dummy variables
to account for interactions between the levels of different
dimensions, and the model selected by McGhee et al. [19]
included one such term, MOST, which takes the value of 1 if
any dimension in the health state is at one of the most severe
levels, and 0 otherwise (Most severe is deﬁned as levels 4–6 for
physical functioning, 3 and 4 for role limitation, 4 and 5 for social
functioning, mental health, and vitality, and 5 and 6 for pain.)
Estimation of this random effects model is via generalized
least squares or maximum likelihood. Because αj has 0 mean, the
population health state utility for state x in this model is simply
μ^þ h^′IðxÞ.
The Nonparametric Approach
The models used in all previous analyses have, like (2), been
parametric. They have therefore imposed a particular form on
the utility function. Kharroubi et al. [15] proposed a nonpara-
metric approach that allows the function to take any form at all,
using Bayesian hierarchical modeling. In this section, we review
some of the methods and results in Kharroubi et al. [15]. This is
necessary to ease the development in the subsequent sections
and to facilitate comparison with parametric results in the
article.
Kharroubi et al. [15] build a new Bayesian statistical non-
parametric model to describe the intrinsic characteristics of
individual health state valuation data that they argued is more
theoretically appropriate than previous parametric models. For
respondent j, the health state utility of state xij is
f ðxij,αjÞ¼1expðαjÞ 1uðxijÞ
  ð3Þ
Note that the individual respondent term αj enters multiplica-
tively rather than additively as in (2). The term u(x) is the median
health state utility of health state x. (In the Kharroubi et al. [15]
model, the distribution of αj is normal, and so it has 0 median as
well as 0 mean, and the median of expðαjÞ is therefore 1.) It is
treated as an unknown function, and in Bayesian framework, it
therefore becomes a random variable. The prior distribution for
u(x) is
u xð ÞNðγþb′x,s2Þ ð4Þ
Note that x is a vector comprising discrete levels on each of the
six health dimensions. Note also that the mean function of (4)
represents a belief that the utility will be approximately linear
and additive in the different dimensions, but whereas (2) imposes
this linearity and additively as a strict assumption about the
utility function, our model simply expresses it as a prior expect-
ation. The hierarchical model says that the function is morelikely to be close to the linear, additive form than to be very
different from that form, but this prior distribution will be
modiﬁed by the data. It will thereby adapt to whatever functional
form is suggested by the data. If the data are particularly strong,
they will overrule the prior expectation. In practice, the data will
generally be less strong, in which case the prior model will
smooth the empirical relationship suggested by the data toward
the form suggested by the mean function of (4). (See Kharroubi
et al. [15] for more details.)
Furthermore, the values of uðxÞ and uðx′Þ for two different
states x and x′ have a correlation cðx,x′Þ that decreases as the
distance between x and x′ increases. This is deﬁned as
cðx,x0Þ¼exp ∑bd xdxd 0ð Þ2
n o
,
where for d ¼ 1, 2,…, 6, xd and xd 0 are the levels of dimension d in
the health states x and x′, respectively, and bd is a roughness
parameter in dimension d. As discussed in [15], this function
plays a key role in determining how closely the utility function is
constrained by the prior distribution toward the parametric form
of the mean function of (4). Many other choices might be made
for this covariance function, but the resulting estimates are not
generally sensitive to the form of the function. The roughness
parameters control how closely the true utility function is
expected to adhere to a linear form in each dimension. We adopt
default values of these parameters, as discussed in [15], that
create a substantial correlation between neighboring health
states to represent the local smoothness and linearity of the
utility function but the correlation falls away rapidly to allow the
general shape of the function to respond to the data.
Note that the mean health state utility in (3) is
uðxÞ¼1α 1uðxÞ 
where α is the mean value of expðαÞ over the whole population.
This will not in general be 1, and so the population (mean) health
state utility is not the same as the median health state utility
u(x). More details of the nonparametric modeling and evaluation
of α are given in Kharroubi et al. [15].
For this article, the variable αj is allowed to vary because this
captures the impact of respondent characteristics. Suppose that tj
is the vector of covariates for respondent j. We then propose
αjNðtj 0θ,τ2Þ
where θ is the vector of coefﬁcients for the covariates. Note here
that t’s are centered to ensure that they have 0 means, and hence
that the value of expðαÞ for a typical person is 1.
The models and the programs to undertake the Bayesian
approach were written in Matlab and are available on request.
Comparison of Models
The two models cannot be compared in terms of a simple table of
coefﬁcients as in McGhee et al. [19] because the nonparametric
model produces in effect a separate parameter for all the 18,000
health states. Given that the overall aim is to predict health state
valuations, the best way to compare these models is via their
predictive ability.Results
The models are compared in terms of their predictive ability in
Figures 1 and 2, where the predicted and actual mean values for
the 197 health states valued in the survey have been plotted with
health states ordered by predicted health state values (Figs. 1 and
2 have been plotted by ordering states in terms of their predicted
values rather than observed values as presented in Brazier et al.
[9] and McGhee et al. [19]. This is better on statistical grounds and
Fig. 1 – Sample mean and predicted health states valuations for the parametric model.
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mean health state valuations (line marked with squares) for the
parametric model (2), along with actual mean health state
valuations (line marked with diamonds). The line marked with
triangles represents the errors obtained by the difference
between the two valuations. Figure 2 presents the corresponding
plots for the nonparametric model. The plots suggest that the
parametric model overpredicts the value of the better states,
whereas this does not seem to have been a problem for the
nonparametric model. The plots also suggest that the variations
of the predictions are larger, and so a nonsteady trend of the
difference (line marked with triangles) for the parametric model.
This provides an initial indication that the nonparametric model
is less prone to systematic bias.
To better quantify the gains in terms of bias/precision,
Figure 3 shows the Bland-Altman agreement plot [22], where
the difference scores of the predicted and actual mean healthFig. 2 – Sample mean and predicted health statestate valuations are plotted against the average scores of the two
valuations for the parametric model. The solid line represents the
average bias (or the average of the differences), and the dotted
lines are the 95% limits of agreement. Figure 4 presents the
corresponding agreement plot for the nonparametric model. The
presentation of the 95% limits of agreement is for visual judg-
ment of how well the two valuations agree. The smaller the range
between these two limits, the better the agreement is. The plots
suggest that the nonparametric model shows good agreement as
the width of the 95% limits of agreement is 0.197, which is
narrower than that of the parametric model with a width of
0.324. Although the average bias for both models is close to 0,
with values of 0.011 for the nonparametric model and – 0.020 for
the parametric model, the SD of the differences for the non-
parametric model is rather smaller than for the parametric
model, with values of 0.050 and 0.0825, respectively. This justiﬁes
the large variations of the differences in Figure 3. In contrast, it iss valuations for the nonparametric model.
Fig. 3 – Bland-Altman agreement plot for the
parametric model.
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are well validated.
Table 2 shows the inference for the mean health state utility
values of the 197 health states valued in the Valuation Survey.
For each state, Table 2 reports the observed sample mean health
state utility and the predicted mean and SD for the population
mean health state utility from both the nonparametric and
parametric models. Across the 197 states that were used in the
study, the predictive performance of the nonparametric model is
better than that of the parametric model overall, with a root
mean square error (RMSE) of 0.051 for the nonparametric model
and 0.085 for the parametric model.
For both models, no state is estimated as being worse than
death. Important differences, however, can be seen between the
models from Table 2. The parametric model estimates the health
state utility for the pits state to be 0.169, even though the
observed average for this state is 0.067, whereas the nonpara-
metric model achieves a value of 0.098. At the other end of the
scale, the parametric model is more prone to overpredict milder
states. It can also be seen that the SDs of the predictions are
larger for the parametric model. The parametric SDs are larger
because they are based on the assumption that the preference
function is additive in the various factors, apart from the MOST
term. The posterior SDs are smaller primarily because it is aFig. 4 – Bland-Altman agreement plot for the
nonparametric model.model that admits uncertainty about the shape of the health
state utility function.
The overall impact of this can be seen from the plots in Figures
5 and 6, which show, respectively, the predicted values using the
parametric and nonparametric models against observed mean
values of the 197 health states, with perfect prediction indicated
by a 45-degree line of unity (solid line). Figures 5 and 6 show that
the magnitude of the differences in predicted and observed mean
valuations increased with decreasing valuations of these health
states. The magnitude of differences, however, is more obvious in
Figure 5 for the parametric model. Furthermore, Figure 6 shows
that the predicted mean health state values for the nonparametric
model form a scatter around the line with no strong pattern, while
Figure 5 shows a larger scatter and the points deviate systemati-
cally from the 45-degree theoretical line; therefore, the parametric
model is not well validated by its predictive performance. In
contrast, it is apparent from Figure 6 that the nonparametric
model predictions are well validated.
As always, it is important to check the validity of the assumed
models. Figure 7 plots a histogram of standardized residuals
across all 4596 health state valuations for the parametric model,
and Figure 8 plots the corresponding standardized residuals for
the nonparametric model. According to these models, we would
expect these to be approximately N (0, 1). Figures 7 and 8 broadly
support this, although there is some evidence of skewness, which
is more obvious in Figure 7. This is not surprising, given the
negative skewness in the original SG data at the individual level.
The degree of skewness, however, is probably not high enough to
invalidate the analyses in both models, which assume normally
distributed errors.
A better test of the validity of the model is to investigate its
ability to predict the values for states that have not been used in
the estimation. Data relating to 30 selected health states were
removed randomly from the estimation data, and the models
ﬁtted on data for the remaining 167 states. Table 3 presents the
true sample means for the 30 omitted states, together with their
predicted mean and SD values from the parametric and non-
parametric models estimated on the reduced data set. The
predictive performance of the nonparametric model is better
than that of the parametric model overall, with RMSEs of 0.056
and 0.071, respectively. It can be seen that the nonparametric
model predicts the omitted data quite well, and better than the
parametric model. It is to be noted that the predictive SDs here
for both models are larger than those in Table 2, because the
model in Table 2 is predicting the data on which it was estimated,
whereas the model in Table 3 is predicting out of sample data.
The parametric standard errors are larger than the nonparamet-
ric ones, primarily because the nonparametric analysis is able to
make use of other evaluations by the same respondents to
estimate their individual random effects, which the frequentist
analysis cannot do.
Figures 9 and 10 show the Q-Q plots of standardized predictive
errors for the 30 health states sample means, for the parametric
and nonparametric models, respectively. In each ﬁgure, the
straight line corresponds to a reference line passing through
the ﬁrst and third quartiles, which is helpful for judging whether
the points are linear. Figure 9 suggests that the parametric model
is not well validated by its predictive performance. In contrast, it
is apparent from Figure 10 that the nonparametric model pre-
dictions are well validated. Note that although these results are
for omitting one set of 30 health states chosen at random, we
have obtained almost identical results across ﬁve replicates.
To capture the impact of the respondent characteristics,
Figure 11 shows the histograms of the conditional posterior
distribution functions of the covariates’ sex and age. These
results indicate that age and sex have strong effects because
they are not centered on 0. To demonstrate the impact of
Table 2 – Inference for the 197 health states.
Health
states
N Observed
mean
Posterior inference, mean  SD
Nonparameteric (no
covariates)
Parameteric Nonparameteric
(covariates)
111621 23 0.6492 0.6322  0.029 0.7445  0.0683 0.6136  0.0316
111645 19 0.5055 0.5568  0.0281 0.6056  0.0748 0.5343  0.0308
112153 17 0.6519 0.6681  0.0293 0.7594  0.0788 0.6519  0.0306
112455 20 0.6777 0.635  0.0298 0.6654  0.0730 0.6172  0.0315
112613 16 0.7305 0.6636  0.0321 0.7305  0.0812 0.6475  0.0342
112651 20 0.6288 0.6182  0.0335 0.6448  0.0729 0.5996  0.0349
113141 22 0.8022 0.7665  0.0287 0.8283  0.0698 0.7541  0.0303
113352 22 0.7441 0.7304  0.0262 0.7383  0.0706 0.717  0.0275
113411 23 0.7324 0.7208  0.0287 0.9298  0.0677 0.7063  0.0296
113615 17 0.6685 0.6308  0.0334 0.6536  0.0787 0.6125  0.0346
113634 18 0.64 0.5971  0.0305 0.6659  0.0772 0.5777  0.0317
114631 16 0.7057 0.6418  0.0343 0.6927  0.0813 0.6239  0.0357
115131 19 0.7243 0.7203  0.029 0.8053  0.0746 0.7068  0.0309
115211 18 0.7951 0.7739  0.0309 0.8158  0.0768 0.7632  0.0334
115251 21 0.6223 0.6427  0.0287 0.6879  0.0713 0.626  0.0304
115314 18 0.6788 0.6585  0.0312 0.7737  0.0771 0.6414  0.0328
115355 18 0.5346 0.5649  0.0306 0.5868  0.0766 0.5422  0.0332
115432 19 0.6201 0.6673  0.0265 0.7528  0.0751 0.6511  0.027
115653 30 0.5728 0.5189  0.0308 0.5252  0.0600 0.4944  0.0322
121212 20 0.8253 0.8452  0.0249 0.9046  0.0735 0.8376  0.0259
122233 22 0.6894 0.6882  0.0273 0.8075  0.0712 0.6726  0.0286
122425 25 0.704 0.6764  0.0262 0.6977  0.0666 0.6611  0.0279
124125 24 0.612 0.6194  0.0279 0.6911  0.0678 0.602  0.0287
125143 20 0.6505 0.6515  0.0284 0.6849  0.0735 0.6354  0.0299
125625 18 0.5478 0.5187  0.0326 0.4902  0.0772 0.4962  0.0344
131151 17 0.7621 0.7591  0.0293 0.7941  0.0786 0.7476  0.031
131331 18 0.7638 0.7103  0.0292 0.8474  0.0770 0.6953  0.0306
131542 28 0.7067 0.6407  0.0276 0.7121  0.0636 0.623  0.0292
131555 21 0.5327 0.5345  0.0313 0.5922  0.0717 0.5104  0.0326
132524 24 0.5983 0.5944  0.0265 0.6828  0.0687 0.5742  0.0271
133132 21 0.7425 0.7093  0.0266 0.8057  0.0719 0.6949  0.0283
135155 20 0.6251 0.5928  0.032 0.5731  0.0727 0.572  0.0342
135312 27 0.7 0.6814  0.0272 0.7568  0.0640 0.6648  0.0281
135435 20 0.655 0.6194  0.0291 0.6276  0.0731 0.6004  0.0303
135633 18 0.5085 0.5205  0.0304 0.5648  0.0771 0.4971  0.032
141215 20 0.7089 0.6916  0.0303 0.7396  0.0732 0.6765  0.032
142113 20 0.6585 0.7071  0.0277 0.8091  0.0729 0.6936  0.0289
142154 28 0.6821 0.6494  0.0281 0.6729  0.0626 0.6313  0.0291
142335 18 0.6654 0.6164  0.0294 0.6672  0.0774 0.5981  0.031
143641 19 0.5733 0.5495  0.0329 0.5933  0.0750 0.5285  0.0332
143654 21 0.5028 0.5145  0.0306 0.5066  0.0715 0.4905  0.0322
144341 27 0.5565 0.5856  0.0275 0.6986  0.0643 0.5665  0.0284
144455 17 0.5676 0.5839  0.0299 0.5541  0.0791 0.5634  0.0315
144613 16 0.6916 0.6136  0.0334 0.6191  0.0814 0.5942  0.0347
145515 19 0.5903 0.5834  0.0322 0.5720  0.0749 0.5641  0.0332
145621 19 0.6093 0.6026  0.0315 0.5549  0.0749 0.5814  0.0328
145645 20 0.5814 0.5391  0.0316 0.4160  0.0729 0.5158  0.0334
145652 18 0.5291 0.4771  0.0328 0.4633  0.0767 0.4513  0.0359
211111 24 0.8584 0.9219  0.0181 0.9509  0.0661 0.918  0.0194
211251 21 0.6738 0.6901  0.0278 0.7504  0.0720 0.6728  0.0287
211615 17 0.6206 0.6458  0.0307 0.6482  0.0791 0.6275  0.0333
211633 20 0.7051 0.62  0.0319 0.6688  0.0736 0.6015  0.0333
212145 26 0.6188 0.5961  0.0277 0.6792  0.0659 0.5756  0.0282
213323 31 0.6571 0.6767  0.0228 0.7752  0.0610 0.6608  0.0238
214435 20 0.5943 0.6097  0.0272 0.6643  0.0739 0.5911  0.0282
221452 23 0.6627 0.6727  0.0261 0.7007  0.0698 0.6567  0.0274
224612 24 0.6385 0.6217  0.0288 0.6311  0.0686 0.6028  0.03
232111 25 0.7796 0.7564  0.0273 0.8388  0.0665 0.7448  0.028
235224 23 0.6506 0.632  0.0271 0.6125  0.0708 0.613  0.0285
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Table 2 – continued
Health
states
N Observed
mean
Posterior inference, mean  SD
Nonparameteric (no
covariates)
Parameteric Nonparameteric
(covariates)
241135 18 0.5824 0.5989  0.0297 0.6800  0.0772 0.5784  0.031
241531 24 0.6643 0.6189  0.0275 0.6972  0.0681 0.5999  0.0286
243433 19 0.5053 0.5941  0.0259 0.6771  0.0758 0.5742  0.0267
243615 20 0.5913 0.5651  0.0301 0.5264  0.0734 0.543  0.0311
244353 20 0.6976 0.5863  0.0307 0.5711  0.0741 0.5668  0.0322
311654 20 0.6581 0.5414  0.0336 0.5749  0.0733 0.5192  0.0355
312332 25 0.701 0.7068  0.0241 0.8120  0.0673 0.6929  0.025
315123 18 0.5582 0.5361  0.0312 0.6942  0.0773 0.5145  0.0316
315235 17 0.6161 0.5866  0.0291 0.6061  0.0796 0.5675  0.0309
315341 18 0.6486 0.592  0.0307 0.6791  0.0776 0.5718  0.0323
315515 24 0.6064 0.5686  0.0295 0.5967  0.0677 0.5474  0.0314
321122 32 0.7987 0.7525  0.0256 0.8251  0.0593 0.7396  0.027
323644 24 0.4377 0.4567  0.0298 0.5342  0.0685 0.4304  0.03
324155 17 0.6248 0.5536  0.0334 0.5720  0.0796 0.5301  0.0349
325433 22 0.5685 0.5845  0.0262 0.6497  0.0705 0.5627  0.0273
331115 19 0.6584 0.6649  0.0275 0.7589  0.0748 0.647  0.0286
332411 25 0.6152 0.6523  0.0246 0.8077  0.0663 0.6344  0.025
333135 20 0.631 0.6219  0.0284 0.6686  0.0735 0.6054  0.0288
333455 19 0.6131 0.5588  0.0315 0.5608  0.0753 0.5381  0.0318
334251 26 0.5031 0.5621  0.0266 0.6371  0.0657 0.5405  0.028
341123 23 0.7389 0.6653  0.0296 0.7275  0.0691 0.6481  0.0299
341251 19 0.6023 0.6064  0.0307 0.6678  0.0752 0.5882  0.0321
341414 20 0.7513 0.6503  0.0317 0.7547 0.0734 0.6339  0.0333
341634 20 0.5209 0.5463  0.0297 0.5778  0.0735 0.5255  0.0309
341651 18 0.6015 0.5401  0.0325 0.5472  0.0767 0.5161  0.0338
342613 22 0.6672 0.589  0.0299 0.5988  0.0701 0.5692  0.0314
343425 18 0.6307 0.5981  0.0284 0.5899  0.0775 0.578  0.0297
344633 17 0.5002 0.493  0.0299 0.5189  0.0794 0.468  0.0316
345153 19 0.4966 0.5378  0.0287 0.5503  0.0748 0.5149  0.0302
345355 19 0.4751 0.5036  0.0285 0.4552  0.0751 0.4782  0.0302
345411 20 0.6347 0.6302  0.0303 0.6937  0.0731 0.6118  0.0315
345535 20 0.6564 0.5377  0.0317 0.4717  0.0736 0.5159  0.0337
345553 17 0.4538 0.4548  0.0307 0.4580  0.0794 0.4281  0.0335
411612 20 0.6595 0.6355  0.0305 0.7096  0.0730 0.6174  0.0316
412152 31 0.608 0.5804  0.0254 0.7044  0.0602 0.5585  0.0267
413212 19 0.6879 0.678  0.028 0.7866  0.0756 0.6632  0.0284
414355 18 0.5976 0.5634  0.0294 0.5598  0.0773 0.5418  0.0307
414522 22 0.7007 0.626  0.0303 0.6445  0.0717 0.6081  0.0314
415115 19 0.6264 0.5911  0.0321 0.6712  0.0745 0.5731  0.0339
415313 19 0.5055 0.5672  0.0263 0.7108  0.0750 0.5463  0.0283
415453 20 0.5826 0.5458  0.0301 0.5841  0.0733 0.5237  0.0311
415651 20 0.5347 0.4882  0.0334 0.4961  0.0728 0.4622  0.0353
415655 19 0.4739 0.4259  0.0347 0.3866  0.0745 0.3966  0.0361
421314 25 0.6607 0.658  0.0253 0.7806  0.0667 0.6412  0.0265
421455 19 0.4016 0.5198  0.0275 0.5949  0.0752 0.4961  0.0283
421641 22 0.6118 0.5533  0.0316 0.6105  0.0703 0.5321  0.033
423435 18 0.6172 0.5564  0.0297 0.6324  0.0774 0.5351  0.0312
423615 20 0.6373 0.5312  0.0323 0.5490  0.0733 0.508  0.0348
425131 24 0.5312 0.5876  0.0253 0.7006  0.0675 0.5669  0.0266
431443 26 0.5838 0.5927  0.0261 0.6903  0.0659 0.5727  0.0267
432621 22 0.6423 0.5754  0.0292 0.5976  0.0709 0.5545  0.0307
434211 19 0.6601 0.6409  0.0302 0.7472  0.0754 0.6238  0.0315
435335 22 0.6579 0.5929  0.0295 0.5551  0.0703 0.5733  0.0304
441255 18 0.5133 0.5271  0.0324 0.5405  0.0770 0.5049  0.034
441331 19 0.557 0.5765  0.0277 0.7395  0.0753 0.5554  0.0294
441615 21 0.4883 0.5209  0.0303 0.5478  0.0710 0.4979  0.0316
442655 19 0.353 0.4346  0.0301 0.3858  0.0749 0.407  0.0313
443215 23 0.5719 0.5981  0.0272 0.6247  0.0689 0.5798  0.0276
443652 20 0.4431 0.4242  0.0312 0.4599  0.0734 0.3972  0.0322
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Table 2 – continued
Health
states
N Observed
mean
Posterior inference, mean  SD
Nonparameteric (no
covariates)
Parameteric Nonparameteric
(covariates)
444611 18 0.6854 0.5974  0.0312 0.5900  0.0768 0.5763  0.0328
445145 19 0.3405 0.4903  0.0273 0.5015  0.0751 0.4656  0.0291
445233 19 0.4914 0.5801  0.0267 0.5775  0.0755 0.5598  0.0272
445615 18 0.4775 0.4665  0.0327 0.4363  0.0764 0.4388  0.0344
445641 18 0.5364 0.4739  0.033 0.4542  0.0769 0.4497  0.0345
511114 23 0.6239 0.64  0.0281 0.8097  0.0686 0.6234  0.0291
511435 18 0.6804 0.6422  0.0298 0.6774  0.0770 0.6243  0.0312
511615 17 0.5991 0.5918  0.0313 0.5940  0.0789 0.572  0.0331
511633 20 0.5805 0.5599  0.0298 0.6146  0.0734 0.5385  0.0302
512242 24 0.6013 0.5932  0.0255 0.6725  0.0692 0.5721  0.0265
513654 17 0.4584 0.4182  0.0328 0.4815  0.0796 0.3901  0.0345
515155 17 0.6677 0.5675  0.0348 0.5114  0.0790 0.5461  0.0369
522321 24 0.7164 0.6844  0.0264 0.7028  0.0688 0.6689  0.0272
523551 22 0.6141 0.5167  0.0314 0.5630  0.0713 0.4927  0.0335
531635 23 0.5015 0.5003  0.0292 0.5057  0.0689 0.4764  0.0308
533415 20 0.5342 0.5228  0.0288 0.6389  0.0736 0.5005  0.0301
534113 23 0.5076 0.5266  0.0283 0.7092  0.0693 0.5044  0.0293
541451 19 0.5194 0.5266  0.0286 0.6276  0.0750 0.502  0.0301
543533 21 0.4771 0.4745  0.0293 0.5572  0.0724 0.4491  0.0306
545115 20 0.5171 0.5582  0.0295 0.5611  0.0730 0.5385  0.031
545151 22 0.5136 0.5256  0.0291 0.5427  0.0698 0.5015  0.0304
545353 18 0.5103 0.4303  0.0326 0.4727  0.0773 0.4024  0.0341
545422 31 0.6088 0.5954  0.0253 0.5559  0.0609 0.5755  0.0269
611154 19 0.5961 0.5557  0.0329 0.5744  0.0746 0.5321  0.0343
611221 23 0.681 0.654  0.0319 0.6544  0.0689 0.637  0.0336
611432 19 0.4712 0.5706  0.0267 0.6536  0.0750 0.549  0.0273
611454 20 0.3346 0.4466  0.0286 0.5478  0.0730 0.4194  0.0297
611621 20 0.5816 0.5529  0.0319 0.5338  0.0731 0.5301  0.0324
611645 21 0.4649 0.4731  0.031 0.3949  0.0715 0.4465  0.032
611652 22 0.5207 0.437  0.034 0.4423  0.0696 0.4095  0.0361
612415 20 0.4566 0.5267  0.0292 0.5826  0.0730 0.5052  0.0305
613625 22 0.3453 0.4299  0.0298 0.3807  0.0701 0.4022  0.0311
614135 18 0.5587 0.5224  0.0331 0.5292  0.0771 0.4997  0.0355
614434 24 0.4449 0.4615  0.0281 0.5616  0.0678 0.4351  0.0295
615253 16 0.6248 0.5308  0.0342 0.4351  0.0815 0.5072  0.0365
615315 18 0.5634 0.5097  0.0334 0.5040  0.0768 0.4869  0.0354
615412 20 0.4129 0.5182  0.0282 0.5888  0.0732 0.4956  0.0301
615451 18 0.4431 0.4499  0.0324 0.4868  0.0765 0.4229  0.0339
615455 19 0.4993 0.4753  0.0327 0.3773  0.0744 0.4475  0.0347
615614 20 0.4344 0.4885  0.0317 0.4340  0.0730 0.4654  0.0329
615631 18 0.5056 0.4574  0.0347 0.4378  0.0766 0.4324  0.0361
615653 17 0.381 0.356  0.0349 0.3145  0.0786 0.3244  0.0362
621135 22 0.4934 0.5417  0.0291 0.5632  0.0700 0.5194  0.0302
622513 33 0.5108 0.529  0.0265 0.5508  0.0589 0.5061  0.0274
623155 18 0.4501 0.4784  0.0315 0.4384  0.0770 0.4516  0.0341
623353 18 0.4256 0.4528  0.0318 0.4780  0.0777 0.426  0.0335
624431 18 0.5694 0.53  0.0319 0.5788  0.0773 0.5079  0.0326
624633 19 0.3082 0.4345  0.0291 0.4065  0.0754 0.4078  0.0301
625141 26 0.5605 0.5398  0.0287 0.5163  0.0649 0.5164  0.0308
631315 18 0.5806 0.5403  0.0326 0.5739  0.0769 0.5188  0.0334
631333 18 0.6175 0.5443  0.0315 0.5945  0.0772 0.521  0.0329
631355 24 0.4479 0.4765  0.0287 0.4460  0.0671 0.4507  0.0299
631632 18 0.4974 0.5252  0.0307 0.4818  0.0770 0.5019  0.033
632615 20 0.5484 0.4831  0.0307 0.4109  0.0731 0.4581  0.0324
633122 25 0.4986 0.5131  0.0278 0.5795  0.0667 0.4906  0.0291
633535 22 0.3343 0.3942  0.0303 0.4190  0.0705 0.3641  0.0309
633653 18 0.4335 0.3644  0.0335 0.3408  0.0770 0.3343  0.0357
635611 20 0.4001 0.4736  0.0314 0.4429  0.0729 0.448  0.0333
635651 16 0.4884 0.3799  0.0378 0.3151  0.0810 0.3501  0.0397
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Health
states
N Observed
mean
Posterior inference, mean  SD
Nonparameteric (no
covariates)
Parameteric Nonparameteric
(covariates)
641114 18 0.6165 0.6008  0.0313 0.6241  0.0766 0.582  0.0319
641132 18 0.4794 0.5182  0.0312 0.6020  0.0769 0.4942  0.0327
641154 17 0.545 0.5188  0.0339 0.4962  0.0787 0.4952  0.0344
641211 18 0.6294 0.5718  0.0348 0.6384  0.0768 0.5515  0.0369
641654 19 0.4842 0.4347  0.0348 0.3395  0.0745 0.4086  0.0356
642151 20 0.5356 0.5119  0.0318 0.5126  0.0729 0.489  0.0333
642313 18 0.5499 0.5278  0.0311 0.5706  0.0772 0.504  0.0317
642453 17 0.5104 0.4419  0.0326 0.4439  0.0791 0.4143  0.0341
642612 26 0.4496 0.4965  0.0282 0.4579  0.0647 0.4718  0.0295
642651 20 0.3731 0.4346  0.0308 0.3559  0.0728 0.4075  0.0326
643125 17 0.5007 0.4801  0.033 0.4593  0.0793 0.4546  0.0335
643143 17 0.463 0.4581  0.0321 0.4972  0.0794 0.4314  0.0337
644614 18 0.4387 0.4161 0.0321 0.4000 0.0771 0.3873  0.0339
644631 18 0.416 0.4415  0.0313 0.4038  0.0768 0.4152  0.0328
645132 17 0.601 0.5009  0.0352 0.4905  0.0791 0.478  0.0358
645154 22 0.4948 0.396  0.0334 0.3848  0.0696 0.3667  0.0351
645235 20 0.3724 0.4562  0.0299 0.3707  0.0733 0.432  0.0317
645415 17 0.6023 0.4761  0.0354 0.4270  0.0785 0.4502  0.0381
645441 21 0.4085 0.4309  0.0314 0.4449  0.0716 0.4032  0.0323
645655 582 0.067 0.0983  0.0226 0.1690  0.0176 0.0544  0.0232
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 3 2 – 1 0 4 5 1041adjusting for age and sex on the mean health state values, results
are presented for the states listed in Table 2 with and without
adjusting for covariates. The actual HK age and sex distributions
were taken from the HK census of 2006 [23]. These results show that
the largest differences between health state values are for the most
severe SF-6D health state. Mean health state values for the pits state
are 0.054 and 0.098 with and without adjusting for age and sex,
respectively, with difference of 0.044. Note that the observed average
for this state is 0.067. This difference declines as states become
milder. This suggests that the magnitude of the gain of moving from
a severe to mild state will be smaller for older age groups. We
consider this ﬁnding in more detail in the Discussion section.Fig. 5 – Sample mean and predicted health stDiscussion
In this article, we have applied nonparametric Bayesian methods
to the existing HK SF-6D valuation data in an attempt to over-
come some of the limitations observed when a parametric
approach has been taken. The method is a replication of the
method used to model the UK data nonparametrically (the
Kharroubi et al. [15–17] articles describe this at length). Thus,
while it does not provide new methodological advances, it further
emphasizes the point made in the Kharroubi et al. articles [15–17]
that the nonparametric approach performs well.ates valuations for the parametric model.
Fig. 6 – Sample mean and predicted health states valuations for the nonparametric model.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 3 2 – 1 0 4 51042We have presented two sets of analyses; the ﬁrst has com-
pared a Bayesian main-effects model with a previously published
conventional main-effects model [19]. The second has used the
ﬂexibility of the nonparametric Bayesian method to examine the
impact of covariates on health state values.
The nonparametric model represents the following important
characteristics of the data more accurately than does the conven-
tional parametric random-effects model:Fig
eathe nature of individual respondent effects,
 repeated measurements from each individual, and
 the skew distribution of individual valuations of a given state.
The model also allows for respondent-level covariates to enter
in a natural way as predictors of individual respondent effects.
These theoretical advantages of the nonparametric model
are reﬂected in the appreciable improvements to the predictive
ability as reﬂected in better RMSE and the standardized pre-
dictive errors in the out of sample validation. The extra. 7 – Standardized residuals for the parametric model for
ch of the 4596 individual health state valuations.ﬂexibility of the nonparametric model and improved perform-
ance, however, come at the expense of computational complex-
ity, and specialist software is needed to estimate the preference
function (see Kharroubi et al. [15] for details). Furthermore, the
resulting estimated preference function cannot be deﬁned by a
simple table of coefﬁcients as in Brazier et al. [9] and McGhee
et al. [19] articles, because in effect there is a parameter for all
the 18,000 health states. There is a loss of transparency, but in
practice it is straightforward to obtain utilities for any required
health states through software available from the author on
request.
As reported earlier, the analysis of covariates showed that age
and sex are important determinant of health state values. This
impact of age and sex on health state values is also shown in
Figure 12, where the posterior mean health state values (for both
males and females) have been drawn against age for three health
states: the pits or the worst state (645655), a moderate state
(423435), and a mild state (211111). For the pits state, the curve
(for both males and females) follows a clear quadratic, with theFig. 8 – Standardized residuals for the nonparametric model
for each of the 4596 individual health state valuations.
Table 3 – Out of sample predictions for 30 health states.
Missing state N True sample mean Posterior inference, mean  SD
Nonparameteric Parameteric
112651 20 0.6288 0.673  0.0662 0.6427  0.0740
114631 16 0.7057 0.6838  0.0624 0.7021  0.0825
115355 18 0.5346 0.5839  0.0712 0.5751  0.0778
131151 17 0.7621 0.6914  0.0719 0.7888  0.0796
135435 20 0.655 0.6041  0.059 0.6142  0.0745
143641 19 0.5733 0.5663  0.0643 0.6024  0.0765
145621 19 0.6093 0.5746  0.0692 0.5599  0.0761
211633 20 0.7051 0.6739  0.0539 0.6770  0.0750
243433 19 0.5053 0.5008  0.0675 0.6863  0.0775
315235 17 0.6161 0.551  0.0618 0.5922  0.0811
333135 20 0.631 0.4777  0.068 0.6491  0.0750
341634 20 0.5209 0.4533  0.0671 0.5749  0.0748
345153 19 0.4966 0.5258  0.0629 0.5402  0.0759
411612 20 0.6595 0.6182  0.064 0.7145  0.0742
415453 20 0.5826 0.524  0.0607 0.5827  0.0748
423435 18 0.6172 0.6121  0.0552 0.6342  0.0790
435335 22 0.6579 0.5964  0.0548 0.5278  0.0718
443652 20 0.4431 0.4542  0.0611 0.4648  0.0749
445641 18 0.5364 0.4848  0.0637 0.4502  0.0784
515155 17 0.6677 0.5976  0.0606 0.4990  0.0801
543533 21 0.4771 0.4964  0.0576 0.5666  0.0741
611221 23 0.681 0.7268  0.0563 0.6648  0.0704
611652 22 0.5207 0.5085  0.0597 0.4503  0.0707
615315 18 0.5634 0.5285  0.0636 0.4895  0.0780
624431 18 0.5694 0.5813  0.0596 0.5892  0.0786
632615 20 0.5484 0.4264  0.0619 0.3910  0.0742
641114 18 0.6165 0.5317  0.067 0.6235  0.0776
642151 20 0.5356 0.5051  0.0696 0.5045  0.0740
643143 17 0.463 0.4847  0.0636 0.5019  0.0812
645441 21 0.4085 0.4744  0.0614 0.4450  0.0732
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 3 2 – 1 0 4 5 1043value increasing until 45 to 50 years of age and then it starts to
fall off gradually for the next 20 years and then more sharply. The
other two states follow the same inverted “U,” but their shape is
less dramatic, particularly for the mildest state. The largest
difference was for the pits state of 0.2825 and 0.3061 for males
and females, respectively, but this difference was less for milder
states. We also see from Figure 12 that the female line is below
the male line for the three health states. The difference, however,
between both males and females follows a clear decline. For theFig. 9 – Q-Q plot of standardized predictive errors for the
parametric model for the 30 out of sample health states.pits state, the difference of 0.075 was big on average. This
difference declines as states become milder (423435) and almost
negligible for the mildest state (211111). This result indicates that
the impact of age and sex depends crucially on the severity of the
states.
There are important similarities to the ﬁndings of another
large-scale survey analyzed by using multivariate techniques, the
UK time trade-off (TTO) valuation of the EQ-5D questionnaire [24].
This study found age, marital status, and sex to be signiﬁcantFig. 10 – Q-Q plot of standardized predictive errors for the
nonparametric model for the 30 out of sample health states.
Fig. 11 – Conditional posterior distribution functions of the covariates age and sex.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 3 2 – 1 0 4 51044variables, with the same direction of impact, and age even had an
inverted U shape, though the maximum was at 45. There was,
however, a concern in the EQ-5D questionnaire study that the age
effect might have been artefactual because a large proportion of
older respondents did not believe that the TTO question for
states worse than being dead was credible [25]. The variant of
TTO used in that survey asked respondents to consider living in
the state they regarded as worse than being dead for x years
followed by 10 – x years in full health. Many older people did not
believe that they would live for 10 years and so perhaps gave a
lower value for x. The SG question here did not suffer from this
artefact and so provides further support that there does seem toFig. 12 – Mean SG utility values by age and sex fobe a genuine age effect that follows this inverted U shape. In
addition, our modeling implies that this effect is not the same
across states, but is steepest for the most severe states and
becomes ﬂatter as states become milder. Analyses by Kharroubi
et al. [17] of the SF-6D data and by Kharroubi and McCabe [18] of
the HUI2 data have also found this type of relationship.
The ﬁndings about age may also reﬂect an adaptation effect or
at least the consequences of experiencing many of the states in
the past or the context of mixing with older and so less on
average healthy individuals. It also may be to do with a person’s
changing living circumstances, with respondents in middle age
being less willing to risk their life because of having greaterr three health states. SG, standard gamble.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 3 2 – 1 0 4 5 1045responsibilities than the young and old. The underlying reasons
for this ﬁnding, however, are not fully understood [26]. The
reasons for sex are also unclear, though the ﬁnding for sex is
consistent with previous work [24].
The observed relationship between age and utility may have
implications for our understanding of the difference between
patient and general population health state values. Because ill
health is positively correlated with age, ceteris paribus, patients’
values are likely to be lower than general population values.
Thus, the degree of adaptation that leads to the observation that
patients value health states more highly than the general
population may be larger than currently thought. At a minimum,
future analyses of comparative data should control for age when
estimating the scale of divergence between patient and general
population values.
This article does not address the policy implications of the
differences found here. For policymakers wishing to use different
tariffs of values by age group or some other background charac-
teristics, the nonparametric Bayesian method provides a more
appropriate way to do this than do traditional modeling techni-
ques. Most policymakers around the world want to use health
states valued by a representative sample of the general popula-
tion [27]. For such a policy, this article presents a method for
adjusting for differences in a survey sample from the general
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